Eli Lilly and Company: History, Vision, and Achievements Eli Lilly and Company is an American pharmaceutical company established in 1876 by Colonel Eli Lilly. The origins of the company can be traced to Colonel Lilly's interest in the manufacturing and supply of high-quality medications that could fight illnesses, offering hope to people who were suffering. Over the last 145 years, the company has grown significantly and has become one of the leading pharmaceutical companies globally. Initially, Eli Lilly and Company focused on producing medicines and drugs that could help in the treatment of acute health issues such as diabetes, mental illness, and cancer. Throughout the years, the company has continually redefined itself and broadened its focus, with significant emphasis on research and development of innovative drugs and therapies, vaccine development, and advocacy to improve global health issues. In keeping with its vision of leveraging science and technology to help humankind, the company invests extensively in research and development. In 2020, Lilly invested $5.1 billion in R&D, a remarkable feat considering the challenges posed by the COVID-19 pandemic. Eli Lilly is committed to combating global public health challenges such as cancer, diabetes, and Alzheimer's disease. The company has developed some of the most popular drugs that are used globally today to treat cancer, including Alimta®, Gemzar®, Lartruvo®, and Verzenio®. Additionally, Lilly has developed essential medicines such as Humalog® (insulin lispro injection), which is used to manage blood sugar levels. The company is equally committed to researching and developing drugs that treat and manage mental health illnesses. They also have a Diabetes Center of Excellence focused on managing the complex illness that is diabetes. In recent years, Eli Lilly has increased its focus on vaccine development, particularly in response to the threat of COVID-19. Eli Lilly is currently working on developing a neutralizing antibody in response to the threat of COVID to treat, reduce hospitalizations, and prevent progression of the disease. In addition to its research and development initiatives, Eli Lilly has an outstanding sustainability program aimed at protecting the environment and reducing the company's carbon footprint. As part of this program, the company uses recycled and water-sustainable materials in its manufacturing processes. Besides, Lilly has implemented advanced energy management systems to reduce energy usage, and the company's facilities are designed to improve employee health and safety. Eli Lilly has received numerous accolades for its contributions to science and medicine, as well as its commitment to environmental sustainability. In 2019, for example, the company was recognized by the Dow Jones Sustainability Index for its sustainability efforts. The company was also named one of the World's Most Ethical Companies® in 2021 by the Ethisphere® Institute. In conclusion, Eli Lilly is a company that is committed to making the world a better place through its contributions to science, medicine, and environmental sustainability. The company's commitment to research and development, as well as innovation, ensures that it remains at the forefront of the pharmaceutical industry. With its outstanding track record of developing life-saving drugs and therapies, Eli Lilly continues to offer hope to those who need it most. Looking into the future, the company seems to be poised to make even more significant contributions and leave an impact on healthcare around the world.